<DOC>
	<DOCNO>NCT02728440</DOCNO>
	<brief_summary>Effects gonadotrophin replacement therapy Lipid Profile Oxidative Stress Parameters Patients Idiopathic Hypogonadotropic Hypogonadism</brief_summary>
	<brief_title>Effects Gonadotropin Replacement Therapy Metabolic Parameters Patients With Hypogonadism</brief_title>
	<detailed_description>30 male patient diagnosed IHH control group 20 healthy case similar age BMI include study . The level advance oxidation protein product ( AOPP ) , thiol , malondialdehyde ( MDA ) , nitric oxide ( NO ) 8-hydroxydeoxyguanosine ( 8-OHdG ) level triglyceride ( TG ) , total cholesterol ( TC ) , high density lipoprotein ( HDL-K ) , low density lipoprotein ( LDL-K ) , Apolipoprotein A1 ( ApoA1 ) Apolipoprotein B100 ( ApoB100 ) measure gonadotrophin therapy .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Serum testosterone concentration &lt; 300ng/dL Absence pituitary hypothalamic mass lesion , Presence gonadotropin response GnRH , diabetes mellitus , arterial hypertension hormone deficiency</criteria>
	<gender>Male</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>